These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7595481)
1. Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression. Standifer KM; Jenab S; Su W; Chien CC; Pan YX; Inturrisi CE; Pasternak GW J Neurochem; 1995 Nov; 65(5):1981-7. PubMed ID: 7595481 [TBL] [Abstract][Full Text] [Related]
2. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo. Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959 [TBL] [Abstract][Full Text] [Related]
3. Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivo. Lai J; Riedl M; Stone LS; Arvidsson U; Bilsky EJ; Wilcox GL; Elde R; Porreca F Neurosci Lett; 1996 Aug; 213(3):205-8. PubMed ID: 8873150 [TBL] [Abstract][Full Text] [Related]
4. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice. Lee CE; Kest B; Jenab S; Inturrisi CE Brain Res Mol Brain Res; 1997 Aug; 48(1):17-22. PubMed ID: 9379841 [TBL] [Abstract][Full Text] [Related]
5. Antisense targeting of delta opioid receptors in NG 108-15 cells: direct correlation between oligodeoxynucleotide uptake and receptor density. Lai J; Crook TJ; Payne A; Lynch RM; Porreca F J Pharmacol Exp Ther; 1997 Apr; 281(1):589-96. PubMed ID: 9103548 [TBL] [Abstract][Full Text] [Related]
6. Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Standifer KM; Chien CC; Wahlestedt C; Brown GP; Pasternak GW Neuron; 1994 Apr; 12(4):805-10. PubMed ID: 8161452 [TBL] [Abstract][Full Text] [Related]
7. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. Negri L; Lattanzi R; Borsodi A; Toth G; Salvadori S Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):203-11. PubMed ID: 10355826 [TBL] [Abstract][Full Text] [Related]
8. Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1). Kest B; Lee CE; Mogil JS; Inturrisi CE Life Sci; 1997; 60(9):PL155-9. PubMed ID: 9048971 [TBL] [Abstract][Full Text] [Related]
9. Antisense mapping DOR-1 in mice: further support for delta receptor subtypes. Rossi GC; Su W; Leventhal L; Su H; Pasternak GW Brain Res; 1997 Apr; 753(1):176-9. PubMed ID: 9125445 [TBL] [Abstract][Full Text] [Related]
10. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Kest B; Lee CE; McLemore GL; Inturrisi CE Brain Res Bull; 1996; 39(3):185-8. PubMed ID: 8866695 [TBL] [Abstract][Full Text] [Related]
11. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists. Sánchez-Blázquez P; García-España A; Garzón J J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133 [TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors. Sánchez-Blázquez P; García-Espãna A; Garzón J J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332 [TBL] [Abstract][Full Text] [Related]
13. Effects of antisense oligodeoxynucleotides against opioid receptors on the receptor mRNA contents. Oka T; Yoshikawa M; Kobayashi T; Kitamura K; Iwao K; Kobayashi H Life Sci; 2001 Apr; 68(19-20):2221-5. PubMed ID: 11358330 [TBL] [Abstract][Full Text] [Related]
14. Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands. Lai J; Bilsky EJ; Porreca F J Recept Signal Transduct Res; 1995; 15(1-4):643-50. PubMed ID: 8903970 [TBL] [Abstract][Full Text] [Related]
15. Ethanol and naloxone differentially upregulate delta opioid receptor gene expression in neuroblastoma hybrid (NG108-15) cells. Jenab S; Inturrisi CE Brain Res Mol Brain Res; 1994 Nov; 27(1):95-102. PubMed ID: 7877460 [TBL] [Abstract][Full Text] [Related]
16. Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor. Pan YX; Cheng J; Xu J; Rossi G; Jacobson E; Ryan-Moro J; Brooks AI; Dean GE; Standifer KM; Pasternak GW Mol Pharmacol; 1995 Jun; 47(6):1180-8. PubMed ID: 7603458 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233 [TBL] [Abstract][Full Text] [Related]
18. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. Ziegler A; Luedke GH; Fabbro D; Altmann KH; Stahel RA; Zangemeister-Wittke U J Natl Cancer Inst; 1997 Jul; 89(14):1027-36. PubMed ID: 9230884 [TBL] [Abstract][Full Text] [Related]
20. [Specific regulation of gene expression in brain by antisense oligodeoxynucleotides]. Yoshikawa M; Oka T Nihon Yakurigaku Zasshi; 1997 Apr; 109(4):187-91. PubMed ID: 9160348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]